申请人:Schering Aktiengesellschaft
公开号:US04186129A1
公开(公告)日:1980-01-29
Novel 5-(substituted phenyl)-oxazolidinones and their sulfur analogs of Formula I ##STR1## wherein R.sub.1 is optionally substituted lower alkyl, cycloalkyl or cycloalkylalkyl; R.sub.2 is hydrogen, optionally substituted lower alkyl, cycloalkyl, cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, alkenyl or a heterocyclic group; R.sub.3 is hydrogen, optionally substituted lower alkyl, alkenyl, alkynyl, optionally substituted aryl, optionally substituted aralkyl, or optionally substituted acyl; R.sub.4 is hydrogen or optionally substituted lower alkyl; R.sub.5 is hydrogen or optionally substituted lower alkyl or optionally substituted lower alkoxycarbonyl; and X is oxygen or sulfur, have valuable pharmacological effects.
五取代苯基噁唑烷酮及其硫代衍生物I式 ##STR1## 其中R.sub.1是可选取代的低碳基、环烷基或环烷基烷基;R.sub.2是氢、可选取代的低碳基、环烷基、环烷基烷基、可选取代的芳基、可选取代的芳基烷基、烯基或杂环基;R.sub.3是氢、可选取代的低碳基、烯基、炔基、可选取代的芳基、可选取代的芳基烷基或可选取代的酰基;R.sub.4是氢或可选取代的低碳基;R.sub.5是氢或可选取代的低碳基或可选取代的低碳氧羰基;X是氧或硫,具有有价值的药理作用。